Related Experiment Video
Updated: Aug 11, 2026
13:41
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Human papillomavirus infection and therapy with interferon
1Department of Obstetrics and Gynecology, University of Louisville School of Medicine, KY 40202, USA.
American Journal of Obstetrics and Gynecology
|April 1, 1995
Summary
Interferon therapy effectively treats condylomata acuminata, regardless of administration route. Further research is needed to compare natural versus recombinant interferon and optimize treatment schedules.
Area of Science:
- Virology
- Dermatology
- Immunology
Background:
- Condylomata acuminata are genital warts caused by human papillomavirus (HPV).
- Interferon is a protein with antiviral and immunomodulatory properties.
- Previous studies have explored interferon as a treatment for condylomata acuminata.
Purpose of the Study:
- To summarize the effectiveness of interferon therapy for condylomata acuminata.
- To evaluate the impact of different administration routes on treatment outcomes.
- To identify areas for future research in interferon therapy for this condition.
Main Methods:
- Systematic review and synthesis of existing studies on interferon therapy for condylomata acuminata.
- Analysis of treatment outcomes based on administration route (intralesional, intramuscular, subcutaneous).
- Identification of research gaps regarding interferon product type and administration schedules.
Main Results:
- Interferon therapy demonstrated effectiveness in treating condylomata acuminata across various studies.
- The route of interferon administration (intralesional, intramuscular, subcutaneous) did not significantly affect treatment success.
- Optimal administration schedules and comparative efficacy of natural versus recombinant interferon remain to be determined.
Conclusions:
- Interferon is a viable therapeutic option for condylomata acuminata.
- Current evidence supports the efficacy of multiple administration routes.
- Further investigation is warranted to refine interferon treatment protocols and product selection.
Related Concept Videos
01:29Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:28Herpes
Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...